Editorial: Genetics and ontogeny in precision therapeutics for children
- PMID: 37964778
- PMCID: PMC10641871
- DOI: 10.3389/fgene.2023.1308169
Editorial: Genetics and ontogeny in precision therapeutics for children
Keywords: developmental pharmacology; drug transporters; drug-metabolizing enzymes; ontogeny; pediatrics; pharmacogenomics; precision medicine.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Genetics and ontogeny in precision therapeutics for children
References
-
- Guo H. L., Zhao Y. T., Wang W. J., Dong N., Hu Y. H., Zhang Y. Y., et al. (2022). Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: a promising "MINT" sequencing strategy and therapeutic "DNA-TG" monitoring. Front. Pharmacol. 13, 941182. 10.3389/fphar.2022.941182 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources